Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 2,533

Document Document Title
WO/1998/013342A1
Sulfonium salts represented by general formula (I) which can cure cationically polymerizable compounds at 100 �C or below and can give one-pack mixtures thereof with cationically polymerizable compounds excellent in storage stability; ...  
WO/1998/008566A1
Mammals are treated for infections or for conditions associated with pathologically proliferating mammalian cell growth (for example, certain cancers, restenosis, benign prostatic hypertrophy) by administration of a manipulator of nitros...  
WO/1998/009002A1
Electrochemically preparing onium hydroxides by (A) providing a cell comprising an anode (11), a cathode (12) and one or more unit cells between the anode and the cathode, each unit cell comprising: four compartments defined by, in seque...  
WO/1997/046521A1
Aliphatic nitrate esters having a sulfur or phosphorus atom 'beta' or 'gamma' to a nitrate group and their congeners having efficacy as neuroprotective agents are described. Preferred nitrate esters may be synthesized by nitration of a 3...  
WO/1997/045115A1
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.  
WO/1997/033866A1
'beta'-anilinoethanethiol compounds of general formula (1) (wherein R is hydrogen or optionally substituted alkyl or aryl; R1 is optionally substituted alkyl or optionally substituted aryl); a process for the preparation of 'beta'-anilin...  
WO/1997/027749A1
Disclosed are nitrosated and nitrosylated 'alpha'-adrenergic receptor antagonists, compositions of an 'alpha'-adrenergic receptor antagonist ('alpha'-antagonist), which can optionally be substituted with at least one NO or NO2 moiety, an...  
WO/1997/022612A1
The trimethylsulphonium salt of N-phosphonomethylglycine is prepared by reacting N-phosphonomethylglycine, preferably in the form of a solid, with an aqueous solution of trimethylsulphonium carbonate or trimethylsulphonium bicarbonate or...  
WO/1997/022590A1
A method of nitrating electron-deficient carbocyclic or heterocyclic aromatic compounds such as pyridines, diazines and triazines and benzenoid aromatics having electron-withdrawing substituents involves first reacting the aromatic speci...  
WO/1997/015552A1
Disclosed are phenylacetic acid derivatives of formula (I) in which the substituents and the index have the following meanings: X is NOCH3, CHOCH3, CHCH3; Y is O or NR; R1, R independently of one another stand for hydrogen or C1-C4 alkyl...  
WO/1997/008140A1
N-sulfonyliminodithio compounds have the formula (I), in which R1 and R2 stand for optionally substituted alkyl, alkenyl or alkinyl, and Ar stands for optionally substituted aryl; also disclosed are processes for preparing these compound...  
WO/1997/008141A1
Sulfonium salt compounds represented by general formula (I): wherein R1 and R2 represent each alkyl, hydroxy, alkoxy, alkylcarbonyl, aromatic carbonyl, aromatic thio or halogeno; R3 represents alkyl; R4 represents optionally substituted ...  
WO/1997/005868A1
The present invention is directed to new therapeutic uses of compounds of formula (I) wherein X and Y are oxygen, sulfur, or (CR'R'')n wherein n is 1 to 4; R is hydrogen, alkyl, or benzyl; R1 and R2 are phenyl, substituted phenyl, naphth...  
WO/1997/005106A1
A method of producing fluorinated organic compounds such as organic sulphur pentafluorides. The method includes the steps of converting a compound such as R1-S-S-R2 into R1SF5 by reaction with an inert solvent of R1-S-S-R2 and elemental ...  
WO/1996/040627A2
Lipid molecules bearing a cationic charge are described. These cationic lipids are useful in the delivery of biomolecules, such as oligonucleotides, nucleic acids, peptides, diagnostic imaging agents, proteins and drug molecules. In the ...  
WO/1996/037459A1
The present invention refers to a process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid dichloride, comprising the reaction in heterogeneous phase between 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid and...  
WO/1996/032946A1
Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising: (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii...  
WO/1996/026185A1
A reagent comprising a compound of formula (I): Rf-M(X)(Z)n-Y-R, wherein R is a hydrocarbon radical advantageously having at most 10 carbon atoms and being selected from alkyls and aryls; Rf is a radical of formula (II): R1-(C'XI'2)m-CF2...  
WO/1996/018607A1
A compound represented by general formula (1) or possible stereoisomers and optical isomers thereof, and medicinally acceptable salts of these compounds, wherein R1 represents SR6 or NHR7; R6 represents C1-C6 alkyl, etc.; R7 represents h...  
WO/1996/018608A1
A compound represented by general formula (1),zor possible stereoisomers and optical isomers thereof, and medicinally acceptable salts of these, (wherein R1 represents SR6 or NR7R8; R6 represents C1-C6 alkyl, etc.; R7 represents hydrogen...  
WO/1996/011183A1
The present invention relates to oxime ethers of general formula (I) and to their isomers and isomer mixtures which are possible in which (a) X is an N atom and Y is an oxygen atom or NH, or (b) X is CH and Y is an oxygen atom, in which ...  
WO/1995/029925A1
A compound consisting essentially of a multidentade ligand including at least two thioether groups for being complexed to Rhodium-105 in specific activities that are sufficiently high for use in formulating therapeutic 105Rh-radiopharmac...  
WO/1995/024387A1
A sulfonium salt compound represented by general formula (I) and a curable composition containing the compound, wherein R1 represents C1-C18 alkyl, hydroxy, C1-C18 alkoxy, C1-C18 alkylcarbonyloxy or halogen, and n represents 0, 1, 2 or 3...  
WO/1995/017373A1
The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful f...  
WO/1995/016676A1
Arthropodicidal compounds, compositions and use of compounds having formula (I), wherein Q, X, Y, R1 and m are as defined in the text.  
WO/1995/014011A2
The present invention relates to novel 5,6-dihydropyrone derivatives and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The 5,6-dihydropyrone derivatives are useful in the development of the...  
WO/1995/014012A1
The present invention relates to novel 5,6-dihydropyrone derivatives and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The 5,6-dihydropyrone derivatives are useful in the development of the...  
WO/1995/009620A1
Novel sulfoximine and sulfodiimine matrix metalloproteinase inhibitors of formula (I), wherein: R1 is selected from the group consisting of lower-alkyl, hydroxy lower-alkyl, amino lower-alkyl, carbamoyl lower-alkyl, lower-alkyl carbonyl,...  
WO/1994/029271A1
A sulfonium salt compound represented by general formula (I), useful as a cationic polymerization initiator, wherein R1 represents benzyl, phenyl, etc.; R2, R3 and R4 represent each hydrogen, alkyl, etc.; R5 represents hydrogen, alkyl, p...  
WO/1994/026701A1
A process is disclosed for the preparation of N_G-monoalkyl-L_-arginine and related compounds and salts thereof, for example N_G-monomethyl-L-arginine by reacting N-alkylaminoiminomethane sulphonic acid of formula (II) with an amino acid...  
WO/1994/022817A1
A process for the preparation of arylsulphurpentafluorides and heteroarylsulphurpentafluorides comprises reacting an aryldisulphide or heteroaryldisulphide with silver difluoride under anhydrous conditions at a temperature of at least 10...  
WO/1994/021606A1
Compounds with insecticidal or acaricidal activity have formula (IA) or (IB), wherein Ra represents hydrogen or from 1 to 4 optional substituents and Rb represents from 1 to 3 optional substituents and wherein A represents an optionally ...  
WO/1994/014436A1
A retroviral protease inhibiting compound of formula (A) is disclosed.  
WO/1994/011460A1
Refrigerant compositions include mixtures of 1,1,2-trifluoroethane and a second component wherein the second component is (CF3)2NF, (CF3)3N, N(CHF2)2(CF3), N(CH2F)(CF3)2, SF5CF2H, SF5C2F5, HFC-236ca, HFC-236cb, HFC-236ea, HFC-254cb, HFC-...  
WO/1994/007183A1
A composition of matter including an onium salt and a method of forming images. The onium salt has a chromophore which absorbs ultraviolet radiation, an S, Se, As, N or P atom which is free of substituents exhibiting a higher energy occu...  
WO/1994/003551A1
This invention relates to C14 to C20 alkoxy monophenyl sulfonium salt initiators having formula (I), wherein R is C14 to C20 alkyl; R1 and R2 are each independently C4 to C20 alkyl and X- is a non-basic, non-nucleophilic anion, which ini...  
WO/1993/025522A1
An economical process for producing thiourea dioxide fluid with reduced chemical loss and energy consumption by mixing a combination of thiourea and a peroxide, a combination of thiourea, a peroxide and a reaction catalyst, or a combinat...  
WO/1993/024634A1
Therapeutic agents and methods for the treatment of immunologically mediated diseases and malignancies of myeloid cell or lymphoid cell origin. These particular methods utilize the characterization of particular activation mechanisms imp...  
WO/1993/012068A1
S-nitrosothiols exert a potent relaxant effect, mediated both by guanylate cyclase, and a cGMP-independent mechanism, upon non-vascular smooth muscle. Such types of smooth muscle include airway, gastrointestinal, bladder, uterine and cor...  
WO/1993/009162A1
Hyperbranched aramids, made from an aromatic aminodicarboxylic acid or an aromatic diaminocarboxylic acid, and optionally an aromatic aminocarboxylic acid are disclosed. The hyperbranched aramids are useful as aids for the processing of ...  
WO/1993/006089A1
Compounds with insecticidal activity have formula (I) wherein R1 is hydrogen, halogen, or a group NR4R5 wherein R4 and R5 are independently selected from hydrogen or alkyl; R2 is a group -S(O)nR6 wherein n is 0, 1 or 2 and R6 is a haloal...  
WO/1992/022526A1
The invention concerns sulphonyl formamidrazones of general formula (I) and their tautomers of general formula (II), in which R?1� is an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl or phenyl group or a resi...  
WO/1992/021734A1
The invention concerns vinyl compounds of formula (I), in which R is H, an alkyl or alkenyl group with 1 to 15 C-atoms which may be unsubstituted, substituted singly by CN or CF�3? or substituted at least singly by halogen, one or more...  
WO1992018465A1
The invention features a compound of the formula W-Y-Q-Z or W-Y-Zwherein W is a farnesyl group, a geranylgeranyl group, a substituted farnesyl group or a substituted geranylgeranyl group; Y is (1); Q is (2), wherein n = 1, 2, 3, 4, 5, or...  
WO/1992/017445A2
S-nitrosothiols exert a potent relaxant effect, mediated by guanylate cyclase, upon non-vascular smooth muscle. Such types of smooth muscle include airway, gastrointestinal, bladder, uterine and corpus cavernosal. Thus, S-nitrosothiols m...  
WO/1992/017176A1
Compounds are disclosed which are retroviral protease inhibitors. Also disclosed are methods of using the compounds and compositions for inhibiting a retroviral protease and for treating an HIV infection.  
WO/1992/014703A1
A process for transforming a carbonyl compound into its corresponding epoxide, which comprises contacting the carbonyl compound with either trimethylsulphonium hydrogen sulphate and/or bis(trimethylsulphonium) sulphate or trimethylsulpho...  
WO/1992/011237A1
The invention relates to sulphonyl formamidoximes of formula (I) or their tautomers (II) in which: R?1¿ and R?2¿ are mutually independently hydrogen, possibly substituted alkyl, alkenyl, alkinyl, cycloalkyl, benzyl or phenyl; R?1¿ is ...  
WO/1992/006683A1
The present invention relates to a method of treating a retrovirus utilizing a compound of the formula (I): (R¿2?)¿n?R¿1?-Ar-X-Y-R(T¿1?)(T¿2?)¿m?. The present invention also relates to pharmaceutical compositions in which the activ...  
WO/1992/003050A1
Fungicidally effective compounds of formula (I) are disclosed.  

Matches 451 - 500 out of 2,533